SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Preventive Visit — Elizabeth Barrett Browning — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientElizabeth Barrett Browning
Date of birth1806-03-06
IdentifiersMRN HR-NI026-SYN-TD; SSN (made up) 000-26-4157
Document date1845-07-13
AuthorClementine Haverford-Asante, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Periodic adult preventive visit. [S]

History of Present Illness

Ms. Barrett Browning is a 39-year-old poet with bronchiectasis diagnosed four months ago, long-term morphine therapy that she is slowly reducing by her own choice, and prolonged grief disorder in weekly grief therapy, who comes for her yearly preventive visit. She does airway clearance twice a day, and her sputum is down to about a tablespoon a day without blood. She takes morphine solution 4 mL (8 mg) twice daily, reduced in two steps from 5 mL since April. She has been out by car twice this summer and walked in the garden. She is writing well and has finished a set of poems she began in the spring. Her periods are regular. She has no new concerns. [S]

ElementDetail
VisitPeriodic adult preventive visit, age 39
LungsStable on airway clearance; no exacerbation since diagnosis
MedicinesMorphine solution 8 mg twice daily; naloxone at home; vitamin D3 1819 units daily
MoodPHQ-2 1; finishing the sixteenth grief therapy session this week

Health risk assessment. Completed by the patient on paper at home and reviewed with her by Dr. Haverford-Asante. [S]

DomainFinding
Self-rated healthFair, and better than in the spring
PsychosocialAbsorbing work and many correspondents; grief easing; financially secure
Substance useAUDIT-C 0; prescribed morphine taken as directed; no other drugs
TobaccoNever uses tobacco; no smokers in her room
Physical activityHome exercise program three days a week; walks in the garden in fine weather
NutritionSmall frequent meals and one supplement drink a day; dairy daily
SleepAbout six hours, better than in the spring
SafetyNo falls; morphine kept locked; naloxone at home; no firearm at home; feels safe at home (intimate partner violence screen negative)
Sexual and reproductive healthNot sexually active; not planning pregnancy; periods regular
Activities of daily livingIndependent

Review of Systems

SystemResultFinding
ConstitutionalNegativeNo fever or weight loss; weight rising
EyesNegativeNo change in vision
Ears, nose, mouth, and throatNegativeNo sinus pain or discharge
CardiovascularNegativeOccasional palpitations, less often than in the spring; no chest pain or ankle swelling
RespiratoryPositiveMorning cough with about a tablespoon of sputum; no blood since the first month; breathless on the second flight of stairs
GastrointestinalPositiveStools firm every two days on morphine; no abdominal pain
GenitourinaryNegativeRegular periods; no urinary symptoms
MusculoskeletalPositiveMild upper back ache at the end of a long day of writing, as for many years; no new pain
IntegumentaryNegativeNo rashes or changing moles
BreastNegativeNo lump, pain or nipple discharge
NeurologicalNegativeNo drowsiness, headaches or weakness
PsychiatricNegativeMood better; no thoughts of self-harm; PHQ-2 1

12 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Morphine sulfate 2 mg/mL oral solution, 5 mL (10 mg) by mouth twice daily, morning and bedtime (20 mg a day; long-standing prescription, continued)5 mL (10 mg) twice daily, morning and bedtimeOral route1838-03-01 to 1845-04-19completedS
Naloxone 4 mg nasal spray, one spray into one nostril for suspected opioid overdose, repeat in 2 to 3 minutes in the other nostril if no response; call 911As needed for suspected overdose; keep two devices at homeNasal route1845-03-16activeS
Cholecalciferol (vitamin D3) 1000 unit (25 mcg) oral tablet, two tablets (1819 units) by mouth dailyTwo tablets dailyOral route1845-03-16activeS
Morphine sulfate 2 mg/mL oral solution, 4.5 mL (9 mg) by mouth twice daily, morning and bedtime (18 mg a day)4.5 mL (9 mg) twice daily, morning and bedtimeOral route1845-04-20 to 1845-06-14completedS
Morphine sulfate 2 mg/mL oral solution, 4 mL (8 mg) by mouth twice daily, morning and bedtime (16 mg a day)4 mL (8 mg) twice daily, morning and bedtimeOral route1845-06-15 to 1845-10-18completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1845-07-13Body height157cmS
1845-07-13Body weight43.8kgS
1845-07-13Body mass index (BMI) [Ratio]17.8kg/m2S
1845-07-13Systolic blood pressure106mm[Hg]S
1845-07-13Diastolic blood pressure66mm[Hg]S
1845-07-13Heart rate82/minS
1845-07-13Respiratory rate16/minS
1845-07-13Body temperature36.7CelS
1845-07-13Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1845-07-13Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]1{score}S
1845-07-13Total score [AUDIT-C]0{score}S

Physical Exam

Vital signs recorded on 1845-07-13; see the Vital Signs section. [S]

SystemFinding
ConstitutionalThin but well; weight 43.8 kg, BMI 17.8; blood pressure 106/66
SkinNo suspicious moles
NeckThyroid normal; no nodes
BreastsClinical breast examination declined; no concerns raised
CardiovascularRegular rhythm; no murmur; no ankle edema
RespiratoryA few coarse crackles at the left base that clear partly with coughing; no wheeze
AbdomenSoft and non-tender
MusculoskeletalMild thoracic kyphosis; no spinal tenderness
PelvicSpeculum examination with a chaperone present; cervix normal; sample taken for HPV testing
PsychiatricBright, engaged, and able to speak of her brother briefly without distress overwhelming her

Problems

ProblemClinical statusVerificationCodeProvenance
Chronic cough with daily yellow sputum, occasional streaks of blood, and breathlessness on stairs, worse in winter, for several years after an illness with blood in the sputum about eight years ago; tuberculosis, nontuberculous mycobacteria and bronchiectasis to be distinguishedresolvedconfirmed R05.3S — Synthetic presenting concern at the index visit, superseded by the diagnosis at the consultation; it echoes her documented chest illness (D).
Non-cystic fibrosis bronchiectasis of the left lower lobe and lingula with chronic Haemophilus influenzae infection and mild airflow obstruction (Bronchiectasis Severity Index 3, mild); tuberculosis and nontuberculous mycobacterial disease excluded; synthetic modern diagnosis chosen for a historical chest illness whose cause is disputedactiveconfirmed J47.9S — Synthetic modern diagnosis; the nature of her historical chest illness remains undetermined (R, disputed).
Long-term prescribed opioid therapy (oral morphine 20 mg a day for many years, for cough, sleeplessness and palpitations), with expected physiological dependence; no opioid use disorder on DSM-5-TR assessmentactiveconfirmed Z79.891S — Synthetic modern problem anchored to her documented prescribed opium (D); tolerance and withdrawal on prescribed opioids do not count toward opioid use disorder.
Prolonged grief disorder after the drowning of her closest brother five years ago, with yearning, self-blame, avoidance of reminders of the sea, and depressive symptoms (PHQ-9 12); no suicidal ideationactiveconfirmed F43.81S — Synthetic modern diagnosis anchored to her documented bereavement (D); not a claim about her real mental health.
Vitamin D deficiency (25-hydroxyvitamin D 15 ng/mL) in a woman who rarely goes outdoorsresolvedconfirmed E55.9S — Synthetic finding at intake; repleted by twelve weeks.
Underweight (BMI 16.8) with a small appetiteactiveconfirmed R63.6S — Synthetic finding at intake.

Assessment and Plan

Personalized prevention plan. A written copy was given to the patient. [S]

ServiceStatusDetail
Blood pressure screeningCompleted today106/66 mmHg
Depression screeningCompleted todayPHQ-2 score 1; already in treatment for grief with PHQ-9 at each chronic-care visit
Unhealthy alcohol use screeningCompleted todayAUDIT-C score 0
Tobacco useCompleted todayNever uses tobacco
Intimate partner violence screeningCompleted todayNegative; feels safe at home
Lipid screening and statin assessmentNot indicatedStatin assessment begins at 40; no risk factors
Diabetes screeningNot indicatedUnderweight, with a normal glucose at her first visit
Breast cancer screeningDueBiennial mammography from 40, next year
Cervical cancer screeningCompleted todayNo record of earlier screening; high-risk HPV test collected today; repeat every five years if negative
Colorectal cancer screeningNot indicatedBegins at 45
HIV screeningUp to dateNegative at her first visit, as part of the tuberculosis work-up
Hepatitis C screeningCompleted todayOnce for adults 18 to 79; sent today
Hepatitis B screeningCompleted todayOnce for all adults (surface antigen, surface antibody and core antibody); sent today before the first vaccine dose
Osteoporosis screeningUp to dateDXA three months ago: Z-scores within the expected range; vitamin D repleted
Folic acidNot indicatedNot sexually active and not planning pregnancy; she will start folic acid and review her medicines before any pregnancy
Tetanus, diphtheria, and pertussisCompleted todayTdap; no record of a booster within ten years
Pneumococcal vaccineCompleted todayPCV20 for chronic lung disease; series complete
Hepatitis B vaccineCompleted todayNo record of vaccination; dose 1 of 2 today, dose 2 at the autumn review
Influenza vaccineDueAt the autumn review; yearly for her lung disease
COVID-19 vaccineDueDiscuss in the autumn with the influenza vaccine
Human papillomavirus vaccineNot indicatedRoutine vaccination ends at 26; shared decision-making to 45: not sexually active, and she chose not to have it
Naloxone and opioid safetyUp to dateTwo naloxone devices at home and in date; morphine in a locked box

Immunizations given today: Tetanus, diphtheria, and acellular pertussis vaccine (Tdap); Pneumococcal conjugate vaccine, 20-valent (PCV20); Hepatitis B vaccine (HepB-CpG), dose 1 of 2 [S]

Guideline basis: CDC Clinical Practice Guideline for Prescribing Opioids for Pain, United States, 2022 (2022); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Adult Immunization Schedule by Age (2026)

Follow-up: Seven-month review in the autumn with the PHQ-9, sputum culture, the second hepatitis B dose and the influenza vaccine. Hepatitis B, hepatitis C and HPV results by phone. Next preventive visit in one year. Next scheduled visit 1845-10-19: seven-month review after an exacerbation: lungs, opioid therapy, mood, safety, weight, and vaccines. [S]

Advance Care Planning

Voluntary advance care planning discussion of about 20 minutes, with her consent. She wants full treatment of any chest infection or bleeding, including hospital care, and would want her poems and papers kept safe if she were ever too ill to manage them. She named a health care agent, recorded in the confidential part of the chart and not named here, and chose not to record other treatment preferences today. To be revisited yearly. [S]